ENTHEON BIOMEDICAL CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.16 CAD | +3.23% |
|
0.00% | +60.00% |
| 18/04 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
| 11/04 | Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding | CI |
| Sales 2022 | 0.19 0.26 15.81 | Sales 2023 | 0.25 0.34 20.87 | Capitalization | 591K 808K 49.27M |
|---|---|---|---|---|---|
| Net income 2022 | -8M -10.94M -667M | Net income 2023 | - 0 0 | EV / Sales 2022 | 57,59,850 x |
| Net cash position 2022 | 680K 930K 56.71M | Net cash position 2023 | 345K 471K 28.73M | EV / Sales 2023 | 9,83,765 x |
| P/E ratio 2022 |
-0.21
x | P/E ratio 2023 |
-1.97
x | Employees | 2 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.86% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +3.23% | ||
| Current month | -20.00% | ||
| 1 month | +28.00% | ||
| 3 months | +60.00% | ||
| 6 months | +60.00% | ||
| Current year | +60.00% |
1 week
0.16
0.23
1 month
0.100.25
Current year
0.050.40
1 year
0.050.40
3 years
0.057.10
5 years
0.0513.50
10 years
0.0513.50
| Managers | Title | Age | Since |
|---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 01/19/01 |
Soo-Whan Kim
DFI | Director of Finance/CFO | - | 07/23/07 |
Andrew Hegle
BRD | Director/Board Member | 46 | 01/20/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 01/19/01 |
Andrew Hegle
BRD | Director/Board Member | 46 | 01/20/01 |
| Director/Board Member | 53 | 05/20/05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.16 | +3.23% | 525 |
| 25/24/25 | 0.155 | -22.50% | 500 |
| 24/24/24 | 0.2 | -13.04% | 53,817 |
| 22/24/22 | 0.23 | +43.75% | 1,600 |
| 19/24/19 | 0.16 | +3.23% | 29,200 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 09:00 pm IST
More quotes
Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is focused on treating addiction and substance-use disorders.
Calendar
23/07/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +60.00% | 1.04M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- ENBI Stock
